Michael A Thompson, MD, PhD
I am passionate about clinical trials, translational and basic science research. It is a tragedy that only 2-7% of adults participate in cancer clinical trials. The treatment standards of care we have today in oncology are built upon the clinical trial leadership and patient participation of the past. I am interested in: early phase (I/II) clinical trials, precision medicine, multiple myeloma and other B-cell malignancies (CLL, lymphoma, etc).